SCHEMBL5147385

SCHEMBL5147385

CC1(C)C(=O)NC(=O)N1CCNc1ncc(Cl)c(-c2nnc(NCc3ccc(F)cc3)s2)n1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.35
BRD4 O60885 1/20 0.34
KAT2B Q92831 1/20 0.34
CYP1A2 P05177 9/20 0.33
USP2 O75604 8/20 0.33
ALDH1A1 P00352 8/20 0.33
HSD17B10 Q99714 7/20 0.33
CASP1 P29466 7/20 0.33
CASP7 P55210 7/20 0.33
HIF1A Q16665 7/20 0.33
CYP3A4 P08684 5/20 0.33
CYP2C19 P33261 5/20 0.33
MEN1 O00255 5/20 0.33
KMT2A Q03164 5/20 0.33
TSHR P16473 4/20 0.33
CYP2C9 P11712 4/20 0.33
LMNA P02545 3/20 0.33
GLA P06280 3/20 0.33
CLK4 Q9HAZ1 2/20 0.33
ALOX15 P16050 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2983794 0.84 MEN1 (0.31) CYP1A2USP2ALDH1A1HSD17B10CASP1
SCHEMBL2985133 0.82 MARK3 (0.36) MAPK1CYP1A2USP2ALDH1A1CASP1
SCHEMBL5147397 0.82 CXCR4 (0.34) MAPK1BRD4KAT2BCYP1A2USP2
SCHEMBL13685201 0.80 CXCR4 (0.34) MAPK1BRD4KAT2BCYP1A2USP2
SCHEMBL2979553 0.80 FGFR1 (0.34) MAPK1CYP1A2USP2ALDH1A1HSD17B10
SCHEMBL2978356 0.80 GUSB (0.39) CYP1A2USP2ALDH1A1HSD17B10CASP1
SCHEMBL2986223 0.79 FGFR1 (0.35) MAPK1CDK9FGFR1AXL
SCHEMBL2988266 0.79 PDE7A (0.43) MAPK1CYP1A2USP2ALDH1A1HSD17B10
SCHEMBL2988264 0.79 PDE7A (0.43) MAPK1CYP1A2USP2ALDH1A1HSD17B10
SCHEMBL2981950 0.77 MAPK1 (0.33) MAPK1CYP1A2USP2ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1831207-B1 AMINOPYRIMIDINE COMPOUNDS AS PLK INHIBITORS AMGEN INC (US) 2012-11-14 EP claimed
EP-1831207-A1 AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE Amgen Inc. (US) 2007-09-12 EP disclosed
WO-2006066172-A1 AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE AMGEN, INC. (US) 2006-06-22 WO disclosed